Search Results - "Albi, Elisa"

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia by Rosati, Emanuela, Baldoni, Stefano, De Falco, Filomena, Del Papa, Beatrice, Dorillo, Erica, Rompietti, Chiara, Albi, Elisa, Falzetti, Franca, Di Ianni, Mauro, Sportoletti, Paolo

“…Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly variable clinical outcomes. In recent years, genomic and molecular…”
Get full text

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B‐CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Bordini, Jessica, Morabito, Alessia, Taccetti, Caterina, Lenzi, Chiara, Ranghetti, Pamela, Perotta, Eleonora, Frenquelli, Michela, Scarfò, Lydia, Albi, Elisa, Ghia, Paolo, Campanella, Alessandro

Get full text

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells by Di Ianni, Mauro, Baldoni, Stefano, Del Papa, Beatrice, Aureli, Patrizia, Dorillo, Erica, De Falco, Filomena, Albi, Elisa, Varasano, Emanuela, Di Tommaso, Ambra, Giancola, Raffaella, Accorsi, Patrizia, Rotta, Gianluca, Rompietti, Chiara, Silva Barcelos, Estevão Carlos, Campese, Antonio Francesco, Di Bartolomeo, Paolo, Screpanti, Isabella, Rosati, Emanuela, Falzetti, Franca, Sportoletti, Paolo

“…To investigate chronic lymphocytic leukemia (CLL)-initiating cells, we assessed mutation/expression in hematopoietic stem cells (HSCs). In mutated CLL, we…”
Get full text

P646: VENETOCLAX RETREATMENT AFTER MRD‐GUIDED VENETOCLAX +/‐ IBRUTINIB: THE IMPROVE STUDY COHORT by Scarfò, Lydia, Heltai, Silvia, Albi, Elisa, Scarano, Eloise, Schiattone, Luana, Farina, Lucia, Moia, Riccardo, Deodato, Marina, Ferrario, Andrea, Motta, Marina, Noto, Alessandro, Sancetta, Rosaria, Coscia, Marta, Rivela, Paolo, Laurenti, Luca, Varettoni, Marzia, Perotta, Eleonora, Capasso, Antonella, Ranghetti, Pamela, Martini, Francesca, Sant’antonio, Emanuela, Combi, Catalina, Colia, Maria, Ghia, Paolo

Get full text

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin by La Starza, Roberta, Pierini, Tiziana, Pastorino, Lorenza, Albi, Elisa, Matteucci, Caterina, Crescenzi, Barbara, Sportoletti, Paolo, Covarelli, Piero, Falzetti, Franca, Roti, Giovanni, Ascani, Stefano, Mecucci, Cristina

“…Collision tumors are rare entities that consist of two histologically distinct tumor types arising in the same anatomic site. An association between chronic…”
Get full text

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia by Albi, Elisa, Capasso, Antonella, Schiattone, Luana, Ghia, Paolo, Scarfò, Lydia

“…With its heterogeneous biological features and clinical course, chronic lymphocytic leukemia (CLL), the most frequent adult leukemia in the Western world, is a…”
Get full text

Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pandemic by Tedeschi, Alessandra, Innocenti, Idanna, Albano, Francesco, Gozzetti, Alessandro, Levato, Luciano, Porrazzo, Marika, Reda, Gianluigi, Albi, Elisa, Chiarenza, Annalisa, Gualberti, Giuliana, Malgieri, Simona, Finsinger, Paola, Trentin, Livio

“…Introduction Although plenty of data exists on efficacy and safety of CLL drugs, their impact on patients' Health-Related Quality of Life (HRQoL) is largely…”
Get full text

Minimal residual disease–driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL by Scarfò, Lydia, Heltai, Silvia, Albi, Elisa, Scarano, Eloise, Schiattone, Luana, Farina, Lucia, Moia, Riccardo, Deodato, Marina, Ferrario, Andrea, Motta, Marina, Reda, Gianluigi, Sancetta, Rosaria, Coscia, Marta, Rivela, Paolo, Laurenti, Luca, Varettoni, Marzia, Perotta, Eleonora, Capasso, Antonella, Ranghetti, Pamela, Colia, Maria, Ghia, Paolo

“…•A sequential MRD-guided addition of ibrutinib to venetoclax led to uMRD in 33 (87%) of 38 patients with relapsed/refractory CLL.•This MRD-driven strategy…”
Get full text

Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study by Albi, Elisa, Scarfo, Lydia, Heltai, Silvia, Scarano, Eloise, Schiattone, Luana, Farina, Lucia, Moia, Riccardo, Deodato, Marina, Ferrario, Andrea, Motta, Marina, Noto, Alessandro, Sancetta, Rosaria, Coscia, Marta, Rivela, Paolo, Laurenti, Luca, Varettoni, Marzia, Perotta, Eleonora, Capasso, Antonella, Ranghetti, Pamela, Martini, Francesca, Sant'Antonio, Emanuela, Combi, Catalina, Colia, Maria, Ghia, Paolo

“…Data from small cohorts of patients (pts) with chronic lymphocytic leukemia (CLL) relapsing after venetoclax-based fixed-duration regimens suggest that…”
Get full text

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL by Capasso, Antonella, Albi, Elisa, Schiattone, Luana, Martini, Francesca, Sant'Antonio, Emanuela, Scarfò, Lydia, Ranghetti, Pamela, Frenquelli, Michela, Campanella, Alessandro, Perotta, Eleonora, Heltai, Silvia, Colia, Maria, Ghia, Paolo

“…Chronic lymphocytic leukaemia (CLL) is associated with some degree of immune dysfunction as a result of the disease itself and/or treatment. COVID-19 has a…”
Get full text

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia by Del Papa, Beatrice, Baldoni, Stefano, Dorillo, Erica, De Falco, Filomena, Rompietti, Chiara, Cecchini, Debora, Cantelmi, Maria Grazia, Sorcini, Daniele, Nogarotto, Manuel, Adamo, Francesco Maria, Mezzasoma, Federica, Silva Barcelos, Estevão Carlos, Albi, Elisa, Iacucci Ostini, Roberta, Di Tommaso, Ambra, Marra, Andrea, Montanaro, Guido, Martelli, Maria Paola, Falzetti, Franca, Di Ianni, Mauro, Rosati, Emanuela, Sportoletti, Paolo

“…Ibrutinib, a Bruton tyrosine kinase inhibitor (BTKi), has improved the outcomes of chronic lymphocytic leukemia (CLL), but primary resistance or relapse are…”
Get full text

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL by Capasso, Antonella, Albi, Elisa, Schiattone, Luana, Martini, Francesca, Sant'Antonio, Emanuela, Scarfò, Lydia, Ranghetti, Pamela, Frenquelli, Michela, Campanella, Alessandro, Perotta, Eleonora, Heltai, Silvia, Colia, Maria, Ghia, Paolo

Get full text

An Observational Study on Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens Outside Clinical Trials in Italy (GIMEMA CLL1920) by Scarfo, Lydia, Albi, Elisa, Quaglia, Francesca M., Marasca, Roberto, Sanna, Alessandro, Murru, Roberta, Laurenti, Luca, Gaidano, Gianluca, Mannina, Donato, Gentile, Massimo, Patti, Caterina, Reda, Gianluigi, Piciocchi, Alfonso, Fazi, Paola, Soddu, Stefano, Pietrasanta, Daniela, Orsucci, Lorella, Molica, Stefano, Ferrario, Andrea, Ferrari, Angela, Sportoletti, Paolo, Angeletti, Ilaria, Galimberti, Sara, Chiarenza, Annalisa, Morelli, Francesca, Mauro, Francesca, Cuneo, Antonio, Ghia, Paolo

“…Venetoclax is the first BCL-2 inhibitor approved for the treatment of patients with chronic lymphocytic leukemia (CLL) alone or in combination with anti-CD20…”
Get full text

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study by Sportoletti, Paolo, Laurenti, Luca, Chiarenza, Annalisa, Gaidano, Gianluca, Albi, Elisa, Mauro, Francesca Romana, Trentin, Livio, Vallisa, Daniele, Pane, Fabrizio, Cuneo, Antonio, Albano, Francesco, Zamprogna, Giulia, Coscia, Marta, Gozzetti, Alessandro, Reda, Gianluigi, Caira, Morena, Finsinger, Paola, Gualberti, Giuliana, Iannella, Emilia, Malgieri, Simona, Molica, Stefano

“…Chronic lymphocytic leukemia (CLL) therapies differ in efficacy, side effects, route, frequency, and duration of administration. We assessed patient…”
Get full text

Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study by Scarfo, Lydia, Heltai, Silvia, Albi, Elisa, Scarano, Eloise, Schiattone, Luana, Farina, Lucia, Gaidano, Gianluca, Deodato, Marina, Ferrario, Andrea, Motta, Marina, Reda, Gianluigi, Sancetta, Rosaria, Coscia, Marta, Ladetto, Marco, Laurenti, Luca, Varettoni, Marzia, Perotta, Eleonora, Capasso, Antonella, Ranghetti, Pamela, Colia, Maria, Ghia, Paolo

“…The treatment of chronic lymphocytic leukemia (CLL) has been radically changed in the last years thanks to the targeted therapies, including kinase (i.e…”
Get full text

NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells by Di Ianni, Mauro, Baldoni, Stefano, Del Papa, Beatrice, Dorillo, Erica, Albi, Elisa, Giancola, Raffaella, Accorsi, Patrizia, Screpanti, Isabella, Rosati, Emanuela, Di Bartolomeo, Paolo, Falzetti, Franca, Sportoletti, Paolo

“…Chronic lymphocytic leukemia (CLL) is a B cell disorder characterized by constitutive NOTCH1 activation. NOTCH1 mutations are recurrently associated with CLL…”
Get full text

Ibrutinib Treatment of a Patient with Relapsing Chronic Lymphocytic Leukemia and Sustained Remission of Richter Syndrome by Albi, Elisa, Baldoni, Stefano, Aureli, Patrizia, Dorillo, Erica, Del Papa, Beatrice, Ascani, Stefano, Di lanni, Mauro, Falzetti, Franca, Sportoletti, Paolo

“…Purpose Richter syndrome (RS) is a rare event in chronic lymphocytic leukemia (CLL) that is influenced by biological factors and prior CLL treatments…”
Get full text

P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS‐COV‐2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL by Campanella, Alessandro, Capasso, Antonella, Taccetti, Caterina, Heltai, Silvia, Albi, Elisa, Herishanu, Yair, Haggenburg, Sabine, Chatzikonstantinou, Thomas, Doubek, Michael, Kättström, Magdalena, Giannopoulos, Krzysztof, Simkovic, Martin, Moreno, Carol, Massaia, Massimo, Bumbea, Horia, Shimmari, Salem Al, Ranghetti, Pamela, Perotta, Eleonora, Martini, Francesca, Sant’antonio, Emanuela, Colia, Maria, Combi, Catalina, Levi, Shai, Kater, Arnon, Hazenberg, Mette, Nijhof, Inger, Hofsink, Quincy, Demosthenous, Christos, Kotaskova, Jana, Zaleska, Joanna, Vrbacky, Filip, Mora, Alba, Bisogno, Davide, Tripoli, Ignazio Ezio, Popov, Viola Maria, Roman, Viviana, Scarano, Eloise, Frenquelli, Michela, Scarfò, Lydia, Stamatopoulos, Kostas, Ghia, Paolo

Get full text

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin by La Starza, Roberta, Pierini, Tiziana, Pastorino, Lorenza, Albi, Elisa, Matteucci, Caterina, Crescenzi, Barbara, Sportoletti, Paolo, Covarelli, Piero, Falzetti, Franca, Roti, Giovanni, Ascani, Stefano, Mecucci, Cristina

“…BACKGROUNDCollision tumors are rare entities that consist of two histologically distinct tumor types arising in the same anatomic site. An association between…”
Get full text